GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kobo Biotech Ltd (BOM:531541) » Definitions » Institutional Ownership

Kobo Biotech (BOM:531541) Institutional Ownership : 2.25% (As of May. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kobo Biotech Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kobo Biotech's institutional ownership is 2.25%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kobo Biotech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kobo Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.


Kobo Biotech Institutional Ownership Historical Data

The historical data trend for Kobo Biotech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobo Biotech Institutional Ownership Chart

Kobo Biotech Historical Data

The historical data trend for Kobo Biotech can be seen below:

2007-03-31 2007-04-30
Institutional Ownership 2.25 2.25

Kobo Biotech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Kobo Biotech (BOM:531541) Business Description

Traded in Other Exchanges
N/A
Address
Saki Vihar Road, Unit 104, HYDE Park, Opp. Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.

Kobo Biotech (BOM:531541) Headlines

No Headlines